The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / October / Mapping Conjunctivitis Risk in Uganda
Cornea Health Economics and Policy News

Mapping Conjunctivitis Risk in Uganda

Researchers identify person-to-person exposure as the only factor independently associated with increased conjunctivitis prevalence

10/30/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Scorecard
  • Quiz
  • Poll
5 Key Takeaways
  • 1

    Among 423 patients attending Gulu Regional Referral Hospital’s eye clinic, 298 (70.4%) were diagnosed with conjunctivitis.

  • 2

    The clinic-based proportion reflects convenience sampling and should not be interpreted as conjunctivitis prevalence in Northern Uganda’s general population.

  • 3

    After adjustment, recent exposure to someone with conjunctivitis was associated with a 13% higher prevalence of the disease.

  • 4

    Patients aged 40 years or older had a 27% lower prevalence than children aged 0 to 11 years.

  • 5

    The cross-sectional study used clinical diagnoses, did not distinguish conjunctivitis subtypes, and could not establish causality.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: